Opinion
Video
Author(s):
Medical experts highlight key data from the FRESCO-2 trial on fruquintinib for previously treated metastatic colorectal cancer, focusing on study population, efficacy, and safety, and discuss real-world experience with fruquintinib compared with trial outcomes.
Video content above is prompted by the following:
OS Disparity, Driver Gene Variations by Race and Ethnicity Seen in CRC
Expert Highlights Need for Greater Diversity in Dermatology Clinical Trials